Medical Condition News

RSS

'Natural killer' cells could be a powerful weapon to fight against lung cancer

Immune cells called 'natural killer' (NK) cells could be a powerful weapon for fighting lung cancer, according to Australian researchers.

1 Sep 2020

Study offers hope for Norwegians suffering from chronic sleep disorders

Approximately 500 000 Norwegians suffer from chronic sleep disorders, also called insomnia. Researchers have long known that cognitive behavioural therapy for insomnia is the best documented treatment, but few people have access to such therapy.

1 Sep 2020

Common heart drugs are safe for patients hospitalized with COVID-19

Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.

1 Sep 2020

Surgeons use patients' own stem cells to rebuild damaged corneas

Surgeons at Massachusetts Eye and Ear have replaced the ocular surface of four patients who each experienced chemical burns to one eye by using their own stem cells taken from the other healthy eye, in a technique known as "cultivated autologous limbal epithelial cell transplantation" (CALEC).

1 Sep 2020

Brain estrogen critical for astrocyte activation and neuroprotection

When the brain isn't getting enough oxygen, estrogen produced by neurons in both males and females hyperactivates another brain cell type called astrocytes to step up their usual support and protect brain function.

1 Sep 2020

Warnings can protect memory from misleading information

Warning witnesses about the threat of misinformation - before or after an event - significantly reduces the negative impact of misinformation on memory, according to new research performed at Tufts University.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf, in collaboration with the Dutch Network for Cardiovascular Research (WCN) in the Netherlands, confirmed that low dose colchicine was safe, well-tolerated over the long-term, and significantly reduced the risk of cardiovascular death, heart attack, and ischemic stroke in patients with chronic coronary disease.

1 Sep 2020

Innovative training protocol leads to real physical and cognitive benefits

Researchers at the Smart-Aging Research Center (IDAC) at Tohoku University have developed an innovative training protocol that, utilizing immersive virtual reality (IVR), leads to real physical and cognitive benefits.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf,

1 Sep 2020

Patients with cancer and COVID-19 infection can experience blood clots

UC researchers and physicians are learning that COVID-19 impacts more than just the lungs. The list of potential issues multiplies when doctors also consider its impact on patients with other underlying conditions or the medications used to treat those conditions.

1 Sep 2020

Diminished biological arousal before global pandemic may predict PTSD symptoms

People who did not have a large heart rate response to a stress task surprised researchers later -- after the onset of the COVID-19 pandemic -- when they showed more symptoms of post-traumatic stress disorder related to the crisis than others who also did the stress task and COVID-19 stress ratings.

1 Sep 2020

$Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction$

Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction

Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart failure with preserved ejection fraction

1 Sep 2020

Study: Impact of COVID-19 virus goes far beyond the pulmonary system

Described as a novel, "once-in-a-century" disease, COVID-19 research is evolving to include a growing body of evidence that the virus's impact goes far beyond the pulmonary system.

1 Sep 2020

Adjuvant chemotherapy can improve overall survival in patients with high-risk, low-grade glioma

A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.

1 Sep 2020

Heart structure could explain why risk of heart disease differs between men and women

Differences in the shape and texture of men and women's hearts could potentially explain why their risk of heart disease differs, according to research funded by the British Heart Foundation (BHF).

1 Sep 2020

New study weighs effectiveness of three anticonvulsant drugs to treat deadly seizures

Three anticonvulsant drugs commonly used to stop prolonged, potentially deadly seizures each work equally well, according to a national study led by physicians at UT Southwestern.

31 Aug 2020

Unique antibody profile differentiates people with non-celiac gluten sensitivity

A new study of the antibodies produced by people with gluten sensitivity may lead to a better way to detect the condition and treat it.

31 Aug 2020

New microgel drug delivery method could improve effectiveness of pancreatic islet transplants

Pancreatic islet transplants, which revive insulin production to treat type 1 diabetes, only last an average of three years.

31 Aug 2020

People with genetic risk for Alzheimer's have spatial navigation problems

An international research team headed by Anne Bierbrauer, Dr. Lukas Kunz, Dr. Carlos Gomez and Professor Nikolai Axmacher from Ruhr-Universität Bochum and Universitätsklinikum Freiburg now reports that problems in spatial navigation can also be detected in people with a genetic risk for Alzheimer's.

31 Aug 2020

FEFU scientists to design genetically modified models for understanding malignant gliomas

Scientists of Far Eastern Federal University get started studying the formation and survival mechanisms of the brain malignant tumors cells, i.e. glioma, to reveal new ways for diagnosis and therapy for this fatal disease.

31 Aug 2020

Medical Condition News

'Natural killer' cells could be a powerful weapon to fight against lung cancer

Study offers hope for Norwegians suffering from chronic sleep disorders

Common heart drugs are safe for patients hospitalized with COVID-19

Surgeons use patients' own stem cells to rebuild damaged corneas

Brain estrogen critical for astrocyte activation and neuroprotection

Warnings can protect memory from misleading information

Low dose colchicine significantly reduces risk of cardiovascular death

Innovative training protocol leads to real physical and cognitive benefits

Low dose colchicine significantly reduces risk of cardiovascular death

Patients with cancer and COVID-19 infection can experience blood clots

Diminished biological arousal before global pandemic may predict PTSD symptoms

Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction

Study: Impact of COVID-19 virus goes far beyond the pulmonary system

Adjuvant chemotherapy can improve overall survival in patients with high-risk, low-grade glioma

Heart structure could explain why risk of heart disease differs between men and women

New study weighs effectiveness of three anticonvulsant drugs to treat deadly seizures

Unique antibody profile differentiates people with non-celiac gluten sensitivity

New microgel drug delivery method could improve effectiveness of pancreatic islet transplants

People with genetic risk for Alzheimer's have spatial navigation problems

FEFU scientists to design genetically modified models for understanding malignant gliomas

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News